HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$29.00
Day range
$28.80 - $31.19
Year range
$18.92 - $43.15
Market cap
3.52B USD
Avg Volume
3.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 164.74M | 256.28% |
Net income | -157.66M | -345.16% |
Net profit margin | — | — |
Earnings per share | -1.38 | -331.25% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 705.74M | -21.81% |
Total assets | 715.73M | -21.20% |
Total liabilities | 76.67M | 173.39% |
Total equity | 639.06M | — |
Shares outstanding | 115.55M | — |
Price to book | 5.21 | — |
Return on assets | -56.61% | — |
Return on capital | -60.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -157.66M | -345.16% |
Cash from operations | -85.29M | -173.53% |
Cash from investing | 75.61M | 1,048.42% |
Cash from financing | 75.10M | 7,410.30% |
Net change in cash | 65.43M | 376.43% |
Free cash flow | -29.11M | -47.08% |
About
CEO
Founded
2012
Website
Employees
53
